Iliana Sorotou
Papers
1
Total Citations
8
H-Index
1
About
Iliana Sorotou is a rising leader in surgical oncology, with a focused expertise in minimally invasive and robotic hepatopancreatobiliary surgery. Her most cited work, a 2025 systematic review of randomized controlled trials, provides a critical comparative analysis of open, laparoscopic, and robotic pancreaticoduodenectomy. This landmark study, already garnering 8 citations, synthesizes limited RCT data to evaluate postoperative outcomes, including complications, length of stay, and oncologic efficacy. Sorotou’s major contribution lies in clarifying the evidence base for adopting robotic and laparoscopic approaches over traditional open surgery, offering a balanced assessment that guides clinical decision-making. Her work addresses a pressing need for high-quality evidence in a field where technological adoption has outpaced rigorous trials. By systematically analyzing the available RCTs, she has helped define the safety and feasibility profiles of these advanced techniques. Sorotou’s research is instrumental for surgeons and trainees navigating the transition to minimally invasive pancreatic surgery, and her systematic review stands as a foundational reference for future prospective studies. Her scholarship signals a commitment to evidence-based innovation in complex surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1